求人検索
この求人の 取扱い会社 |
マイケル・ペイジ・インターナショナル・ジャパン株式会社/Michael Page International Japan K.K. |
---|---|
企業名 | 会社名非公開 |
職種 |
![]() 営業 - 流通/卸/一般消費財系営業 営業 - メディカル/医薬MR・メディカル業界営業 |
業種 | 製薬メーカー |
勤務地 |
アジア
日本
東京都
|
仕事内容 |
This is a newly created role for a dynamic sales leader to establish the Japan market for an ambitious Chinese biopharma innovator. The position combines high autonomy with a rare opportunity to launch novel regenerative medicine products in both beauty and medical channels. Description * Establish the company's sales operations in Japan from scratch, with a focus on aesthetic product launches first, followed by medical drug sales. * Identify, negotiate, and manage OEM partnerships for local production and distribution. * Develop go-to-market strategy, pricing, and sales execution plans. * Collaborate closely with HQ (CEO and R&D team) to ensure regulatory alignment and product readiness. * Represent the company externally and build credibility with key KOLs, clinics, and distributors. Profile * Minimum 5-6 years of B2B or OEM sales experience in Japan, ideally within pharmaceuticals, aesthetics, or medical devices * Proven track record in new market development, with a hands-on, entrepreneurial mindset * Strong communication and negotiation skills to engage partners, regulators, and internal stakeholders * Business-level fluency in Japanese and English; Mandarin proficiency preferred * Must hold a valid Japan work visa or permanent residency Job Offer 💰 Attractive annual base salary (flexible for exceptional candidates) 🚀 First-in-market opportunity to lead an innovative product launch 🎯 Exclusive ownership of the Japan strategy with direct CEO exposure 🌱 Be part of a purpose-driven company revolutionizing wound healing and aesthetics To apply online please click the 'Apply' button below. For a confidential discussion about this role please contact Sara Loh on +813 6832 8915. |
企業について (社風など) |
Our client is a rapidly growing biopharmaceutical company founded in 2012 and backed by a visionary second-generation CEO. Specializing in PDGF (platelet-derived growth factor) drugs for wound healing and aesthetic treatments, the firm has a robust R&D pipeline and is positioned to commercialize several first-in-class therapies in Asia over the next 3-5 years. |
英語能力 | ビジネス会話 (TOEIC 735-860) |
日本語能力 | 流暢(日本語能力試験1級又はN1) |
年収 | 日本・円 1000万円 〜 1500万円 |
給与に関する説明 | bonus |